Inpatient and Outpatient Orderable

MYD88 L265P Mutation Molecular Detection

Synonyms	LAB14271 MYD88 L265P MUTATION ANALYSIS
Cerner Name	HLX MYD88 L265P Case
Clinical Info	MYD88 L265P mutation is present in approximately 90% of cases of Waldenstrom macroglobulinemia (WM)/lymphoplasmacytic lymphoma (LPL) cases. Detection of MYD88 L265P mutation is useful in differentiating LPL from other B-cell lymphoproliferative disorders with overlapping clinicopathological features.
Specimen Sources	Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous Bone Marrow
Specimen Types	Aspirate Blood Bone Marrow
Container	Lavender Top Tube
Collection Instructions	Container/Tube: Lavender Top Tube Specimen: 1-3 mL Whole Blood or Bone Marrow
Specimen Volume	1-3 mL Whole Blood or Bone Marrow
Transport Instructions	Room Temperature
Specimen Stability	Specimens are stable for a week refrigerated
Methodology	Allele specific Real Time PCR
Days Performed	Monday through Friday. TAT: 8 calendar Days
Performing Laboratory	Northwell Health Laboratories
CPT	81305
PDM	248467
Only Orderable at Locations:	Orderable Everywhere
Results
Result Interpretation Detected (mutation is present) Not detected (mutation is absent)
Forms	Heme/Onc Requisition Molecular test Requisition Form

LAB14271

Synonyms